Pacific Edge - Latest News [Page 1]

Pacific Edge Reports Another Year of Commercial Progress

Thursday, 26 May 2016, 11:08 am | Pacific Edge

Cancer diagnostics company Pacific Edge Limited (NZX: PEB) has reported another year of commercial progress and growth as it continues to gain traction for its bladder cancer diagnostic products in the United States and other targeted markets. More >>

Confirmation of Director Appointment

Tuesday, 5 April 2016, 12:53 pm | Pacific Edge

Pacific Edge Limited (PEB:NZX) has today advised that David Levison’s appointment as a Director has been confirmed, effective as at 2 April 2016. More >>

Pacific Edge Announces New Commercial Partnership

Wednesday, 17 February 2016, 11:27 am | Pacific Edge

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has announced a new commercial partnership with Tolmar Australia Pty Limited, a specialised uro-oncology company which provides medicine and support to men with advanced prostate cancer. More >>

Pacific Edge Named in TIN100 Top 10 List

Thursday, 10 September 2015, 3:27 pm | Pacific Edge

Pacific Edge’s global growth and positive revenue trajectory has been recognised with the cancer diagnostics company named number 5 in the TIN100 Top Ten list of Hot Emerging Companies for 2015. More >>

Pacific Edge’s Cxbladder Detect Outperforms Other Diagnostic

Monday, 25 May 2015, 12:12 pm | Pacific Edge

Dunedin, NZ and Hershey, PA (May 25, 2015): Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used tests ... More >>

Pacific Edge’s half year report

Thursday, 18 December 2014, 1:56 pm | Pacific Edge

• Signed Cxbaldder agreement with Multiplan, a large National Provider Network (NPN) in the US. This is the fourth agreement to be signed with NPNs since October 2013. More >>

Pacific Edge launches Cxbladder Triage

Monday, 8 December 2014, 2:23 pm | Pacific Edge

Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder cancer. More >>

Pacific Edge Reports Commercial Progress and Revenue Growth

Friday, 28 November 2014, 12:43 pm | Pacific Edge

Pacific Edge Limited (NZX: PEB) has today announced its interim results for the six months to 30 September 2014, with strong revenue growth reflecting the Company’s positive commercial progress following the launch of its revolutionary bladder cancer ... More >>

Europe patent for colorectal cancer prognostic technology

Wednesday, 26 November 2014, 1:35 pm | Pacific Edge

The European Intellectual Property Office which operates across 38 countries including all European Union members, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. More >>

Correction on Pacific Edge Limited Patent Issue

Wednesday, 26 November 2014, 1:34 pm | Pacific Edge

Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe. More >>

Pacific Edge announces appointment of CFO

Thursday, 13 November 2014, 3:36 pm | Pacific Edge

Pacific Edge is pleased to announce the appointment of Kate Rankin as Chief Financial Officer with effect from 17 November 2014. More >>

Pacific Edge Appoints Charles Sitch as Independent Director

Friday, 19 September 2014, 4:10 pm | Pacific Edge

Pacific Edge is pleased to announce the appointment of Charles Sitch as an Independent Director. More >>

US grants Pacific Edge patent for melanoma detection

Thursday, 4 September 2014, 2:20 pm | Pacific Edge

The United States Patent Office has granted Pacific Edge patent protection for 'Prognosis Prediction for Melanoma'. The patent covers the technology being used to develop the melanoma prognostic test that will enable clinicians to distinguish aggressive ... More >>

Kaiser Permanente signs up for Cxbladder

Wednesday, 27 August 2014, 12:05 pm | Pacific Edge

Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente’s health care network. More >>

Pacific Edge AGM addresses

Friday, 22 August 2014, 5:05 pm | Pacific Edge

Chairman and CEO addresses to the Pacific Edge annual shareholders meeting held in Dunedin late Thursday afternoon. More >>

Building Presence in World’s Largest Biomedical Market

Friday, 22 August 2014, 10:26 am | Pacific Edge

At its annual shareholders’ meeting held yesterday in Dunedin, New Zealand, cancer diagnostic developer, Pacific Edge, celebrated the commercial launch of its flagship bladder cancer diagnostic product, Cxbladder, into the US and provided shareholders ... More >>

Bladder cancer testing service goes live in NZ

Tuesday, 29 July 2014, 12:06 pm | Pacific Edge

All New Zealand residents and healthcare professionals can today access the Cxbladder cancer detection technology developed by Dunedin-based Pacific Edge with the ‘go live’ of an e-commerce platform. More >>

FY14 Marks Significant Commercial Milestone for Pacific Edge

Wednesday, 28 May 2014, 2:03 pm | Pacific Edge

The 2014 Financial Year marked a significant commercial milestone for Pacific Edge as the Company celebrated the start of revenue generation in its primary market, the USA, alongside a strong year of market development and customer capture. More >>

Pacific Edge signs Cxbladder agreement with MultiPlan

Monday, 26 May 2014, 10:38 am | Pacific Edge

Pacific Edge announced today that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostics laboratory testing. The agreement includes Pacific Edge’s participation in the MultiPlan, PHCS and PHCS Savility Networks. More >>

Pacific Edge named Top Bioscience Company in 2014

Friday, 2 May 2014, 11:35 am | Pacific Edge

Pacific Edge has been named NZBIO’s top bioscience company for 2014. Pacific Edge was specifically recognised for building the profile and credibility of biotechnology and biotechnology companies in New Zealand. More >>



InfoPages Links



Search Scoop  
Powered by Vodafone
NZ independent news